Christopher Ruthruff
Family Medicine · Ionia, MINPI 1831144179
Payments from drug & device makers
Across 262 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$882
- AbbVie$465
- Pfizer$415
- AstraZeneca$357
- Boehringer Ingelheim$302
- Otsuka America Pharmaceutical, Inc.$256
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,604100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $882 |
| AbbVie(2 entities) | 26 | $465 |
| Pfizer | 28 | $415 |
| AstraZeneca | 23 | $357 |
| Boehringer Ingelheim | 16 | $302 |
| Otsuka America Pharmaceutical, Inc. | 13 | $256 |
| GSK | 12 | $222 |
| Dexcom, Inc. | 8 | $174 |
| Astellas Pharma US Inc | 7 | $160 |
| Lilly USA, LLC | 9 | $151 |
| Lundbeck LLC | 6 | $121 |
| Teva Pharmaceuticals USA, Inc. | 7 | $102 |
| Merck | 5 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $86 |
| Exact Sciences | 5 | $84 |
| Amgen | 6 | $83 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Bayer | 5 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Corium, LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Intuitive Surgical | 1 | $21 |
| Nevro Corp. | 1 | $21 |
| Phadia US Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Circassia Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$4,604 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $92,256 |
| RybelsusSemaglutide | 46 | $63,694 |
| JardianceEmpagliflozin | 67 | $60,727 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $52,548 |
| TrulicityDulaglutide | 43 | $47,136 |
| MounjaroTirzepatide | 42 | $45,040 |
| FarxigaDapagliflozin Propanediol | 34 | $33,542 |
| OzempicSemaglutide | 26 | $31,108 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 34 | $30,860 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 41 | $29,241 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $28,601 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $17,722 |
| XareltoRivaroxaban | 13 | $14,030 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 11 | $13,556 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $12,668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic, Xultophy 100-3.6 | $882 | $108,35883 claims |
| PfizerEliquis | $415 | $92,25688 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $151 | $92,17685 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $302 | $91,587101 claims |
| GSKTrelegy Ellipta | $222 | $52,54847 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $357 | $51,13766 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $73 | $29,24141 claims |
| Johnson & JohnsonXarelto | $26 | $14,03013 claims |
| MerckJanuvia | $97 | $8,51612 claims |
| Astellas Pharma US IncMyrbetriq | $160 | $7,00814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Ionia
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.